Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow
Publication
, Conference
Jamy, O; Bae, S; Costa, LJ; Erba, HP; Papadantonakis, N
Published in: BLOOD
December 7, 2017
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Jamy, O., Bae, S., Costa, L. J., Erba, H. P., & Papadantonakis, N. (2017). Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow. In BLOOD (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
Jamy, Omer, Sejong Bae, Luciano J. Costa, Harry P. Erba, and Nikolaos Papadantonakis. “Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow.” In BLOOD, Vol. 130. AMER SOC HEMATOLOGY, 2017.
Jamy O, Bae S, Costa LJ, Erba HP, Papadantonakis N. Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow. In: BLOOD. AMER SOC HEMATOLOGY; 2017.
Jamy, Omer, et al. “Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow.” BLOOD, vol. 130, AMER SOC HEMATOLOGY, 2017.
Jamy O, Bae S, Costa LJ, Erba HP, Papadantonakis N. Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow. BLOOD. AMER SOC HEMATOLOGY; 2017.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology